Finance

Beta
Lists
NVLG:TLV
Novolog Pharm Up 1966 Ltd
ILA 87.50
-1.02%
(-0.90) 1D
Jun 4, 5:26:00 PM GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for NVLG...
Open
ILA 88.40
High
ILA 89.60
Low
ILA 86.50
Mkt. cap
447.02M
Avg. vol.
250.35K
Volume
24.42K
Dividend
5.59%
Quarterly dividend
ILA 1.22
Ex-dividend date
Dec 1, 2025
P/E ratio
126.26
52-wk high
ILA 157.00
52-wk low
ILA 82.70
EPS
ILA 0.01
Shares outstanding
510.87M
No. of employees
916
Open
ILA 88.40
High
ILA 89.60
Low
ILA 86.50
Mkt. cap
447.02M
Avg. vol.
250.35K
Volume
24.42K
Dividend
5.59%
Quarterly dividend
ILA 1.22
Ex-dividend date
Dec 1, 2025
P/E ratio
126.26
52-wk high
ILA 157.00
52-wk low
ILA 82.70
EPS
ILA 0.01
Shares outstanding
510.87M
No. of employees
916
News stories
From sources across the web
About Novolog Pharm Up 1966 Ltd
CEOAviad Bussi
Employees916
Founded1966
Headquarters-
SectorHealth care provider
Previous reportsAll values in ILS
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ILS
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
441.69M
483.58M
373.25M
505.83M
Cost of goods sold
404.36M
447.35M
306.78M
474.69M
Cost of revenue
404.36M
447.35M
306.78M
474.69M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28.81M
26.35M
31.08M
26.07M
Operating expense
17.85M
26.92M
29.91M
26.05M
Total operating expenses
422.21M
474.27M
336.70M
500.75M
Operating income
19.48M
9.31M
36.55M
5.08M
Other non operating income
-
-
-
862.00K
EBT including unusual items
5.25M
6.42M
-6.85M
-608.00K
EBT excluding unusual items
14.25M
5.52M
29.77M
-608.00K
Income tax expense
597.00K
2.16M
-1.23M
-796.00K
Effective tax rate
11.37%
33.59%
17.99%
130.92%
Other operating expenses
-10.96M
567.00K
-1.17M
-19.00K
Net income
4.78M
3.95M
-5.63M
442.00K
Net profit margin
1.08%
0.82%
-1.51%
0.09%
Earnings per share
-
-
-
-
Interest and investment income
804.00K
1.53M
902.00K
-
Interest expense
-6.08M
-5.68M
-3.57M
-6.69M
Net interest expenses
-5.27M
-4.15M
-2.67M
-6.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
36.86M
19.91M
44.43M
23.09M
Gain or loss from assets sale
-54.00K
-
-8.00K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more